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2. Abbreviations 
 
Abs-   Antibodies 
ADRP-  Adipose differentiation-related protein 
ANKRD-  Ankyrin Repeat Domain 
AP-1-   Activator protein-1 
APC-   Adenomatous polyposis coli 
BMP-   Bone morphogenetic protein 
CaMKII-   Ca-Calmodulin Kinase II 
CTGF-  Connective tissue growth factor 
DAG-    Diacylglycerol 
DKK-    Dickkopf  
DN1, 2, 3  Double negative 
DP-   Double positive 
Dvl-   Dishevelled 
DX-   Dexamethasone 
EpCAM1-   Epithelial cellular adhesion molecule 
Fz-    Frizzled 
GH-   Glucocorticoid hormone 
GSK-3-  Glycogen synthase kinase 3 
IER-   Immediate-early response 
IGF-I-   Insulin like growth factor 1 
JNK-   c-Jun N-terminal kinases 
LAP2α-  Lamina associated polypeptide 
LEF1-    Lymphoid Enhancer-binding Factor 1 
LRP5/6-  Low density lipoprotein Related Protein 5 and 6  
MHC-    Major Histocompatibility Complex 
NFAT-   Nuclear Factor of Activating T- cells  
NFκB-   Nuclear Factor kappa B 
Nkd-1,Nkd-2-  Naked 1, 2 
NLK-   Nemo-Like Kinase 
pAb-   Polyclonal antibody 
PCP-   Planar cell polarity pathway  
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PCR-   Polymerase chain reaction 
PKC-    Protein kinase C 
PLC-    Phospholipase C 
PPARγ  Peroxisome proliferator-activated receptor 
qRT-PCR-  Quantitative real-time polymerase chain reaction 
RT-   Reverse transcription 
SEMA-  Semaphorin domain 
TAK1-  Transforming growth factor β–Activated Kinase 1 
TCF1, TCF3-   T-cell Factor 1, 3 
TCR-   T-cell receptor 
TEC-    Thymic epithelial cell  
TMB-   3,3’,5,5’-Tetra-Methyl-Benzidine  
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3. Introduction 
 
3.1. Ageing in focus 
 
3.1.1. Ageing and society 
 
Ageing of the population is one of the most important challenges for the developed world to face 
over the next fifty years. The current demographic trends and consequent shrinkage of the active 
workforce will put enormous pressure on the financing of social protection and health systems, 
which likely to reduce living standards. Coupled with increased migration and emergence of novel 
infectious diseases, broad-scale provision of immunological protection by vaccination constitutes a 
strategic aim for longer and healthier lifespan. 
 
3.1.2. Ageing of the immune system 
 
Impaired immunological responsiveness in the elderly poses a major difficulty for achieving 
efficient immunization. The immunological competence of an individual is determined by the 
presence of mature lymphocytes formed in primary lymphoid organs, and specialized secondary 
lymphoid tissues performing diverse immune responses. Thus at systems level the maintenance of 
immunological equilibrium requires steady lymphocyte output, and controlled expansion coupled 
with continuous replacement. Lymphostromal interactions in both primary and secondary lymphoid 
tissues play essential roles in the development and function of lymphocyte subsets in adaptive 
immune responses. The thymic and lymphnode stromal microenvironments thus represent key 
elements in the development of the adaptive immune system. Consequently, impairment of the 
lymphoid microenvironment will ultimately lead to insufficient primary and secondary immune 
responses or to the decline of thymic selection, manifesting in late-onset autoimmune disorders, 
often observed in elderly. Self-tolerant cytotoxic and helper T-lymphocytes, the crucial regulator 
cells in adaptive immune responses, develop in the specialized epithelial network of the thymus. 
The thymus, however, gradually loses its capacity to support lymphopoiesis in a programmed 
involution process that results in a decline of de novo T-cell production. 
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3.1.3. Significance of thymic involution studies 
 
In contrast to the extensive studies addressing haematopoietic cells, the in-depth analysis of 
determinants for stromal competence during immunological ageing is largely absent, despite its 
clear significance related to immunological responsiveness in the elderly. A more thorough 
understanding of molecular mechanisms responsible for stromal senescence of the thymus may lead 
in aged individuals for the restoration of immunological competence by a controlled reversion of 
the involuted thymic epithelium, and consequent strengthening capacity of peripheral lymphoid 
tissues to support T-cell dependent antibody-mediated immune responses. 
 
3.2. T-cell development in the thymus 
 
T-cell progenitors migrate to the thymus from the bone marrow where they undergo an extensive 
differentiation and selection process. After entering the thymus, thymocytes representing different 
stages of development occupy distinct regions of the thymus. The earliest CD4-CD8-CD44+CD25- 
thymocyte progenitors, referred to as double negative 1 (DN1) cells are found near their site of 
entry at the cortico-medullary junction. The slightly more mature CD4-CD8-CD44+CD25+ (DN2) 
subset is found throughout the cortex, whereas CD4-CD8-CD44-CD25+ (DN3) subset is 
concentrated below the capsule. Following rearrangement of antigen receptor (TCR) genes (He and 
Kappes 2006) CD4+CD8+ (double positive or DP) thymocytes undergo positive (functional TCR) 
and negative (self-reactive TCR) selection in the cortex and medulla, to finally as CD4-CD8+ 
(cytotoxic) or CD4+CD8- (helper) single positive (SP), mature, naïve T-cells leave the thymus for 
the periphery. Figure 1 shows a schematic diagram of T-cell development. 
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Figure 1. T-cell development in the thymus (Nature reviews: Immunology) 
 
3.3. The role of thymic microenvironment in de novo T-cell production 
 
Successful T-cell development requires the interaction of thymocytes with the thymic stroma, 
which creates the special thymic microenvironment for T-cell differentiation and selection. A large 
proportion of the thymic stroma consist of epithelial cells that develop from the epithelial thymic 
anlage from the third pharyngeal pouch around embryonic day 10-11 in the mouse (Manley 2000). 
Following several differentiation steps, including expression of FoxN1 -a member of the forkhead 
transcription factor family (Mandinova, Kolev et al. 2009)– that is essential for Mts24+ epithelial 
progenitors (Bennett, Farley et al. 2002; Gill, Malin et al. 2002) to develop into various epithelial 
subsets (Dooley, Erickson et al. 2005) and to establish the special thymic epithelial cell phenotype 
(Manley 2000). FoxN1 expression in early stages of thymus organogenesis is regulated by secreted 
Wnt4 (Balciunaite, Keller et al. 2002) protein. The mature thymic epithelium consist of two major 
compartments, the cortex and the medulla, which apart from producing chemokines that attract 
haematopoietic stem cells to the thymus, also contribute the special thymic microenvironment. The 
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thymic epithelial network through release of cytokines (e.g. interleukin-7(Alves, Richard-Le Goff et 
al. 2009)), secretion of extracellular matrix components, and establishment of adhesive interactions 
(Crisa L, Cirulli V et al. 1996) (Schluns KS, Cook JE et al. 1997) regulate homing, intrathymic 
migration, and differentiation of developing T-lymphocytes. Thymocytes bearing diverse TCR 
repertoire are selected on MHC (major-histocompatibility-complex) and MHC bound-antigens 
presented to them by the thymic stroma, including epithelial cells. During T-cell development, 
which is characterised by the progression through phenotypically distinct stages (Lind, Prockop et 
al. 2001), thymocytes occupy spatially restricted domains of the mature thymus. T-cell precursors 
enter the thymus at the cortico-medullary junction (Blackburn and Manley 2004), then migrate to 
the subcapsular zone of the outer cortex, back through the cortex, then to the medulla, where they 
finally exit to the periphery (Blackburn and Manley 2004). Functional studies have shown, that the 
cortex is important in producing chemokines, which attract pro-thymocytes (Bleul and Boehm 
2000) and are also essential for mediating positive selection (Anderson, Owen et al. 1994). 
Meanwhile the medullary epithelium has been implicated in driving the final stages of thymocyte 
maturation (Ge and Chen 2000) and has a crucial role in tolerance induction (Farr and Rudensky 
1998; Derbinski, Schulte et al. 2001). Additionally, the thymic epithelium is also the source of other 
secreted and cell surface proteins that regulate T-cell development. These proteins include bone 
morphogenic protein (BMP) (Bleul and Boehm 2005), Notch (Valsecchi C 1997), and Wnt 
(Pongracz, Hare et al. 2003) family members. 
 
3.4. Thymic involution during ageing 
 
In comparison to other organs, ageing of the thymus is an accelerated process in all mammals. In 
humans, thymic senescence begins early, around late puberty and by 50 years of age 80% of the 
thymic stroma is converted to adipose tissue (Dixit 2010). As the thymic epithelium is replaced by 
adipose tissue, the whole process is called adipose involution (Marinova 2005). Due to decrease in 
thymic epithelial tissue mass, the thymus can no longer support the same output of T-cell 
production (Ribeiro and Perelson 2007). T-lymphocyte composition in the periphery therefore 
exhibits the dominance of memory T-lymphocytes resulting in impaired responses towards novel, 
particularly viral infections (Chidgey, Dudakov et al. 2007; Gui, Zhu et al. 2007; Grubeck-
Loebenstein 2009). Since the thymic epithelium has a key role in deleting auto-reactive T-cell 
clones, functional impairment increases the chances of developing auto-immune disease (Hsu and 
Mountz 2003). One of the transcription factors, FoxN1 that is characteristic in thymus development 
is also affected by age. FoxN1 (Mandinova, Kolev et al. 2009) is not only essential for progenitor 
epithelial cells of the thymic rudiment to develop into various epithelial subsets (Dooley, Erickson 
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et al. 2005) but also to maintain TEC (Thymic Epithelial Cell) identity in the differentiated, adult 
thymus. Decreased levels of FoxN1 expression in the adult TECs result in accelerated thymic 
involution (Chen, Xiao et al. 2009; Cheng, Guo et al. 2010). 
 
3.5. Trans-differentiation of fibroblasts into adipocytes 
 
The nuclear lamina consists of a two-dimensional matrix of proteins located next to the inner 
nuclear membrane. The lamin family of proteins make up the matrix and are highly conserved in 
evolution. The family of lamin associated proteins (LAP) has several members with similar 
functions. Studies with fibroblast cells have revealed that fibroblast to pre-adipocyte transformation 
is strongly connected to LAP2α, the member of the LAP2 protein family (Dorner, Vlcek et al. 
2006). While most splice variants associate with the nuclear envelope, LAP2α is involved in several 
nucleoplasmic activities including cell-cycle control and differentiation (Berger, Theodor et al. 
1996; Hutchison, Alvarez-Reyes et al. 2001). LAP2α is synthesized in the cytoplasm and is then 
transported into the nucleus by a PKC-dependent mechanism (Dreger, Otto et al. 1999). The mere 
over-expression of LAP2α in fibroblasts is known to directly up-regulate PPARγ (Peroxisome 
proliferator-activated receptor γ) expression, an acknowledged marker and key transcription factor 
of pre-adipocyte differentiation (Dorner, Vlcek et al. 2006). In pre-adipocytes PPARγ expression is 
followed by an increase of ADRP expression (adipose differentiation-related protein) a known 
direct target gene of PPARγ. Although LAP2α over-expression alone initiates pre-adipocyte 
differentiation in fibroblasts, it is not sufficient to complete the adipocyte differentiation program in 
the absence of additional stimuli (Dorner, Vlcek et al. 2006). 
 
3.6. Wnt signalling 
 
3.6.1. Wnt molecules and pathways 
 
The Wnt family of 19 secreted glycoproteins control a variety of developmental processes including 
cell fate specification, cell proliferation, cell polarity and cell migration. There are two main 
signalling pathways involved in the signal transduction process from the Wnt receptor (Frizzled) 
complex: the canonical or β-catenin dependent and the non-canonical pathway, which diverses into 
the planar cell polarity (PCP) or c-Jun-N-Terminal Kinase (JNK)/Activating Protein (AP1) 
dependent and the Ca++ or Protein kinase C (PKC)/Calmodulin Kinase (CaMKII)/Nuclear Factor of 
Activating T-cells (NFAT) dependent signalling pathways. Based on their ability to activate a 
particular Wnt pathway, Wnt molecules have been grouped as canonical (Wnt1, Wnt3, Wnt3a, 
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Wnt7a, Wnt7b, Wnt8) (Torres, Yang-Snyder et al. 1996) and non-canonical pathway activators 
(Wnt5a, Wnt4, Wnt11) (Torres, Yang-Snyder et al. 1996), although promiscuity is a feature of both 
ligands and receptors alike.  
 
3.6.2. Canonical Wnt-pathway 
 
The canonical or β-catenin/TCF dependent Wnt pathway is extensively investigated, and has been 
shown to be present in the thymus both  in developing thymocytes (Ioannidis, Beermann et al. 
2001; Staal 2001; Xu, Banerjee et al. 2003) as well as in the thymic epithelium (Balciunate, et al 
2001, Pongracz et al 2003). Generally, in the absence of canonical Wnts, glycogen synthase kinase-
3β (GSK-3β) is active and phosphorylates β-catenin in the scaffolding protein complex of 
adenomatous polyposis coli (APC) and axin (Ikeda 1998; Yamamoto 1999). The phosphorylated β-
catenin is targeted for ubiquitination and 26S proteasome-mediated degradation, thereby decreasing 
the cytosolic level of β-catenin (Aberle 1997; Akiyama 2000). In the presence of Wnts, signals 
from the Wnt-Fz-LRP6 complex lead to the phosphorylation of three domains of Dishevelled (Dvl), 
a family of cytosolic signal transducer molecules (Noordermeer 1994). Activation of Dvl ultimately 
leads to phosphorylation and consequently inhibition of GSK-3β. Inhibition of GSK-3β results in 
stabilisation and finally cytosolic accumulation of β-catenin, which then translocates to the nucleus 
(Fig. 2), where is required to form active transcription complexes with members of the T-Cell 
Factor (LEF1, TCF1, TCF3, TCF4) transcription factor family (Staal and Clevers 2003) and 
transcription initiator p300 (Labalette, Renard et al. 2004). 
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Figure 2. Canonical Wnt signalling (Pongracz&Stockley, 2006) 
 
Successful assembly of the transcription complex leads to various target gene activation including 
cyclin-D1 (Shtutman, Zhurinsky et al. 1999; Tetsu and McCormick 1999), c-myc (He, Sparks et al. 
1998), c-jun (Mann, Gelos et al. 1999), Fra-1 (Mann, Gelos et al. 1999), VEGFR (Zhang, Gaspard 
et al. 2001), etc. (Further target genes can be viewed at Nusse’s Wnt website: 
http://www.stanford.edu/~rnusse/wntwindow.html). 
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3.6.3. Non-canonical Wnt-pathways 
 
Generally, the two non-canonical signalling pathways are considered as regulators of canonical Wnt 
signalling and gene transcription. The two non-canonical Wnt pathways, the JNK/AP1 dependent, 
PCP (Polar cell polarity pathway) (Yamanaka, Moriguchi et al. 2002) and the PKC/CAMKII/NFAT 
dependent Ca++ pathway (Wang and Malbon 2003), just like the canonical Wnt pathway, become 
activated following the formation of Wnt-Fz-LRP6 complex (Fig. 3). Although the non-canonical 
pathways differ from the canonical pathway in their dependency on the type of G-proteins (Malbon, 
Wang et al. 2001), activation of Dvl, downstream of Frizzled, is critical for further signal 
transduction in both (Boutros, Paricio et al. 1998; Sheldahl, Slusarski et al. 2003). In further 
contrast to canonical Wnt signalling, phosphorylation of all three domains of Dvl, is not a 
requirement for transduction of non-canonical Wnt signals (Wharton Jr. 2001). Downstream of the 
cytosolic Dvl, the two non-canonical pathways activate different signalling cascades, which either 
involve JNK or PKC with CaMKII and trigger the transcription of different gene-sets. It has been 
proposed for non-canonical Wntsignalling receptors to be linked directly to heterotrimeric G-
proteins that activate phospholipase-C (PLC) isoforms, which in turn stimulate inositol lipid (i.e. 
Ca++/PKC) signalling. Growing evidence, however, indicates that G-proteins are functionally 
diverse and that many of their cellular actions are independent of inositol lipid signalling (Peavy, 
Hubbard et al. 2005), indicating high levels of complexity in both the PKC dependent and 
independent Wnt signalling cascades. The JNK dependent PCP pathway, partly shares target genes 
with the canonical pathway, including cyclin-D1 (Schwabe, Bradham et al. 2003) and matrix 
metalloproteinases (Nateri, Spencer-Dene et al. 2005). Certainly, canonical Wnt signals can be 
rechanneled into the JNK pathway via naturally occurring, intracellular molecular switches, like the 
Dvl inhibitors, Naked-s (Nkd-1, Nkd-2) (Yan, Wallingford et al. 2001) leading to AP1 rather than 
TCF activation. AP1 is not a single protein, but a complex of various smaller proteins, which can 
form homo- and heterodimers (cJun, JunB, JunD, cFos, FosB, Fra1, Fra2, ATF2, and CREB). The 
composition of the AP1 complex is a decisive factor in the activation of target genes therefore, 
regulation of AP1 composition is important. cJun and Fra1, two prominent members of the AP1 
complex are targets of the canonical Wnt pathway (Mann, Gelos et al. 1999), indicating strong 
cross-regulation between the canonical and the non-canonical JNK dependent Wnt signalling 
cascades (Nateri, Spencer-Dene et al. 2005). While there are shared ligands (Rosso, Sussman et al. 
2005; Wang, Shu et al. 2005) and target genes (Shtutman, Zhurinsky et al. 1999; Schwabe, 
Bradham et al. 2003) in the canonical and JNK dependent Wnt pathways, Ca++/PKC dependent 
non-canonical signalling appears to be more independent of the other two pathways although cross-
talk with both the β-catenin and the JNK pathways have been proposed (Kuhl, Geis et al. 2001). 
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Generally, Ca++ and PKC-dependent signals are frequently linked to AP1, NFκB and NFAT 
activation. Gene transcription, however, which is direct result of Ca++ dependent Wnt signalling has 
not been identified. 
 
 
 
Figure 3. Non-canonical pathways of Wnt signalling (Pongracz&Stockley, 2006) 
 
 
3.6.4. Inhibitory Wnt pathway 
 
Besides the canonical and non-canonical Wnt pathways, inhibitory Fz pathways have also been 
described.  Fz1 and Fz-6 are, for example, able to transduce inhibitory Wnt signals. While Fz1 
inhibits Wnt signal transduction via a G-protein dependent manner (Roman-Roman, Shi et al. 2004) 
(Zilberberg, Yaniv et al. 2004), Fz-6 (Golan, Yaniv et al. 2004) inhibits Wnt dependent gene 
transcription by activating  the Transforming growth factor β–activated kinase 1 (TAK1), a member 
of the MAPKKK family, and Nemo-Like Kinase (NLK) (Ishitani, Kishida et al. 2003; Smit, Baas et 
al. 2004) via a Ca++ dependent signalling cascade. NLK phosphorylates TCF that as a result cannot 
bind to β-catenin, consequently formation of the active transcription complex is inhibited (Smit, 
Baas et al. 2004) (Fig. 4). 
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Figure 4.  Inhibitory Wnt pathway (Pongracz&Stockley, 2006) 
 
3.6.5. Wnts in ageing 
 
As Wnts are important regulators of stem cell survival and differentiation, recent studies have 
started to investigate the Wnt family members in ageing. Most studies confirmed that drastically 
reduced Wnt levels can trigger ageing as tissue specific stem cells are depleted as a result of low 
Wnt signals. In contrast, the KLOTHO mouse, that carries a single gene mutation in KLOTHO, an 
endogenous Wnt antagonist also shows   signs of accelerated ageing (Liu, Fergusson et al. 2007). It 
has been proposed that increased Wnt signalling leads to continuous stem cell proliferation which 
finally results in depletion of the stem cell pool causing accelerated ageing  (Brack, Conboy et al. 
2007).  
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3.6.6. Wnts in the thymus 
 
The main source of Wnt glycoproteins in the thymus is the thymic epithelium, where 14 members 
of the Wnt family together with all 10 known Wnt receptors of the seven-loop transmembrane 
receptor family, Frizzleds (Fz) have been identified (Pongracz, Hare et al. 2003). That is a striking 
difference compared with thymocytes where developmentally regulated receptor expression is 
limited to Fz-5 and Fz-6 (Pongracz, Hare et al. 2003). The assembly of an active Wnt-Fz receptor 
complex also requires the presence of a co-receptor, the low density lipoprotein related protein 5 
and 6 (LRP5/6) (Pinson 2000; Tamai 2000; Wehrli 2000), which is expressed both in thymocytes 
and thymic epithelial cells, indicating full ability in both cell types to respond to Wnt signals. Initial 
experiments, by manipulating the level of some Wnts and soluble Fz-s, have shown perturbation of 
T-cell development (Staal 2001; Mulroy 2002), highlighting the importance of Wnt dependent 
signalling for T-cell proliferation and differentiation, but not until data from Pongracz et al 
(Pongracz, Hare et al. 2003) revealed differential expression of Wnt ligands and receptors in thymic 
cell types, was it considered, that T-cell development may be influenced by indirect events triggered 
by Wnt signalling within the thymic epithelium. The canonical pathway has been shown to have an 
important role in thymocyte development regulating survival and differentiation (Ioannidis, 
Beermann et al. 2001; Staal 2001; Pongracz, Hare et al. 2003; Xu, Banerjee et al. 2003). In a thymic 
epithelial cell study, transgenic expression of cyclin-D1, one of the principal target genes of Wnt 
signalling, has lead to the expansion of the entire epithelial compartment (Klug, Crouch et al. 2000) 
suggesting that canonical Wnt signalling is involved in thymic epithelial cell proliferation, 
strengthening the argument, that thymic epithelial development is regulated by Wnts. So far, 
signalling studies have revealed, that Wnt4 can activate both the canonical (Lyons, Mueller et al. 
2004) and the non-canonical (Torres, Yang-Snyder et al. 1996) (Chang, Sonoyama et al. 2007; Kim, 
Clark et al. 2009) Wnt-pathways.  
 
3.7. PKC-s in the thymus 
 
Members of the PKC family regulate a wide variety of cellular processes including proliferation 
(Clemens and Trayner 1992), differentiation (Clemens and Trayner 1992) and apoptotic death 
(Pongracz, Johnson et al. 1994; Pongracz, Tuffley et al. 1995). The PKC family comprises at least 
ten isoenzymes of serine/threonine protein kinases with a broad range of tissue distribution and 
differential cellular localisation (Dekker and Parker 1994). Based on their cofactor requirements for 
optimal catalytic activity, PKC-s are grouped into three main categories (Yamamoto, Takai et al. 
1977; Saito, Kikkawa et al. 2002). While the classical (cPKC: α, βI-βII (splice variants) and γ), and 
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novel (nPKC: δI-III, ε, η, and θI-II) PKC-s bind diacylglycerol (DAG) that stimulates kinase 
activity, atypical (aPKC: ζ, PKMz (catalytic fragment of PKCζ), and ι/λ) PKC-s do not interact 
with DAG (Newton 2001). Ca++ is an additional requirement of cPKC-s but not for nPKC-s. 
Despite that most PKC-s are fully phosphorylated shortly after translation, they remain catalitically 
inactive due to the pseudosubstrate domain. Upon binding of lipid second messengers, like DAG 
and inositol triphosphate, two products of phospholipase-C (PLC) activity, the molecular 
conformation changes and the active centre of the enzymes become exposed and accessible for 
substrates. Catalytically active PKCs usually relocate from the cytosol to cellular or nuclear 
membranes (Giorgione, Hysell et al. 2003). Although PKC-s have been described as having a non-
redundant role in signal transduction of various immune cell types including mature T-cells 
(Monks, Kupfer et al. 1997; Bi K, Tanaka Y et al. 2001) and developing thymocytes (Sun, Arendt et 
al. 2000; Michie, Soh et al. 2001), the expression of PKC family members and their function in the 
thymic epithelium remains obscure. 
 
3.8. PKCs in Wnt signalling 
 
Due to complexity of Wnt signalling as well as PKC activation and regulation, studies targeting 
PKC involvement in Wnt signalling are limited. Wnts of the Ca++ -dependent pathway have been 
demonstrated to trigger PLC activity that is responsible for the generation of lipid second 
messengers, like DAG and inositol phosphates (Cai Y, Stafford LJ et al. 2005). Recently, the 
orphan nuclear receptor RORα-mediated inhibition of canonical Wnt signalling has been identified 
(Lee, Kim et al.) to directly involve PKC. Inhibition of Wnt/β-catenin target genes is achieved by 
Wnt5a/PKCα-dependent phosphorylation of RORα on serine-35 residue. Additionally, Wnt-5a can 
mediate chondro-stimulatory effect of TGF-β3 through upregulation of PKCα and p38MAPK 
signalling (Jin, Park et al. 2006). While PKCδ has been identified as an essential activator of Dvl 
function (Kinoshita, Iioka et al. 2003) a main signal transducer from Fz-s, PKCζ is proposed to 
regulate GSK-3 phosphorylation and activity (Ossipova, Bardeesy et al. 2003). As GSK-3 mediated 
phosphorylation leads to proteosomal degradation of β-catenin (Moon, Bowerman et al. 2002), 
PKCζ modulates the activity of the canonical Wnt pathway (McManus, Sakamoto et al. 2005) (Fig. 
5). 
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Figure 5. The role of PKC isoenzymes in signalling pathways 
 
3.9. Steroids and ageing 
 
Physiological steroids are implicated in the regulation of ageing. For example both surgical or 
chemical castration have been demonstrated to decrease the progression of ageing (Qiao, Chen et al. 
2008)  indicating that high steroid levels would accelerate the ageing process. Still, steroids used in 
therapy have not been fully investigated for their effects on ageing. Autoimmune diseases and 
haematological malignancies are treated by steroids, as they effectively promote apoptosis of 
leukaemia cells and trigger complex anti-inflammatory actions (Stahn, Lowenberg et al. 2007). 
Apart from triggering decreased expression of cytokines and MHC class II (MHC II) molecules, 
glucocorticoid (GC) analogues also induce apoptotic death of peripheral (Wust, van den Brandt et 
al. 2008) and developing T-cells. In mouse models, GCs cause massive thymocyte depletion, 
especially in the CD4+CD8+ (DP) thymocyte population, (Wiegers, Knoflach et al. 2001; Berki, 
Palinkas et al. 2002; Jondal, Pazirandeh et al. 2004) blocking de novo T-cell production. 
Experiments have also demonstrated that high-dose GCs induce a dramatic (Blomgren and 
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Andersson 1970) and apoptosis-associated (Boersma, Betel et al. 1979) involution of the thymus, 
and not only thymocytes but also TECs are seriously affected (Dardenne, Itoh et al. 1986). Recent 
reports (Fletcher, Lowen et al. 2009) have highlighted that TEC depletion appears reversible, and 
thymic epithelial stem cells play an important role in this process.  
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4. Aims of the study 
 
I. To study the role of Wnt signalling in physiological thymic senescence: 
 
1. Wnt4 induced signalling and gene expression patterns were investigated in the thymic 
epithelium. Identification of potential molecular targets of Wnt4 can reveal proliferation, 
differentiation –especially trans-differentiation - patterns within the thymic epithelial network.  
 
2. As Wnt4 can activate both canonical and non-canonical Wnt signalling pathways and regulate 
TEC identity, identification of signalling elements and their role -especially PKCδ- in Wnt4 
signalling can aid better understanding of regulatory mechanisms of thymic senescence. 
 
 
 
II. To compare physiological and induced thymic senescence: 
 
3. Comparison of molecular mechanisms of physiological and GC induced thymic senescence can 
reveal, whether molecular features of the two processes are shared or independent. It can also help 
to identify molecular targets to alleviate side effects of GC therapy and to identify potential 
therapeutic targets to avoid down-regulation of de novo T-cell production. 
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5. Materials and Methods 
 
5.1. Antibodies 
 
5.1.1. Western blot analysis 
 
For western blot analysis rabbit polyclonal anti-PKCδ (C-17), goat polyclonal anti-Dvl (all from 
Santa Cruz) and rat monoclonal anti-Fz-6 (R&D Systems) were used as primary and donkey HRP-
conjugated anti-rabbit, donkey HRP-conjugated anti-goat (Santa Cruz) and rabbit HRP-conjugated 
anti-rat as secondary antibodies. 
 
5.1.2. Fluorescent microscopy 
 
For fluorescent microscopic studies primary Abs were: anti-PKCδ (658-676) pAb (Calbiochem), 
anti-Dvl (C-19) (Santa Cruz), anti-PKCδ (C-17) antibody (Santa Cruz), anti-Fz-4 and anti-Fz-6 
(R&D systems Inc.,), anti-Ly51-PE (clone 6C3), anti-EpCAM-FITC (clone G8.8, American Type 
Culture Collection (ATCC)), DAPI (Serva), ER-TR7-PE (kind gift from professor William van 
Ewijk, Laboratory for Lymphocyte Development, RIKEN Research Center for Allergy and 
Immunology, Yokohama, Japan) and LipidTox Red  (Invitrogen). 
Secondary antibodies were Northern Lights donkey anti-goat IgG-NL493, Northern Lights donkey 
anti-goat IgG557, Northern Lights donkey anti-rabbit IgG-NL557, Northern Lights donkey anti-rat 
IgG-NL493 and anti-rat-Ig-PE secondary antibody (all from R&D Systems).  
 
5.2. Animals 
 
Balb/c mice were purchased from Charles River Hungary Breeding Ltd. The mice were kept under 
standardized conditions where tap water and food was provided ad libitum. Animals were allowed 
to age for 1, 3, 6, 9, 12, 18 months. During this time mice received human care according to the 
Guide for the Care and Use of Laboratory Animals published by the NIH (USA), and the 
experiment was approved by the Animal Research Review Committee of the University of Pecs, 
Medical School (BA02/2000-2/2006). 
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5.3. Cell cultures.  
 
5.3.1 Cell lines 
 
TEP1 (thymic epithelial)(Beardsley, Pierschbacher et al. 1983) (Tanaka, Mamalaki et al. 1993) and 
293 and Phoenix (PHX) human kidney epithelial cell lines were cultured in DMEM  supplemented 
with 10% FCS and 100 µg of penicillin and streptomycin (PAA).  
 
5.3.2 Primary thymic epithelial cells 
 
Balb/c mouse thymi were the source of primary cell material. Primary TECs were purified based on 
their expression of EpCAM1 cell surface marker using anti-EpCAM1-FITC Ab and magnetic cell 
sorter (Miltenyi Biotech). Thymic lobes were from adult Balb/c mice at 24h, 1 week, 1, 3, 6, 9, 12 
or 18  month(s) of age, and from 1.5 year old GFP-transgenic BALB/c-mice. The GFP-transgenic 
BALB/c model was created using lentiviral transgenesis (Kvell, Czompoly et al.).  
 
5.3.3 Dexamethasone treatment of cells and animals 
 
TEP1 cell line was maintained and used for experiments as described in chapter 5.3.1., Wnt4 over-
expressing TEP1 cell line was generated as described in section 5.4.1. Cell lines were treated with 
DX (Sigma, dissolved in DMSO until use) with a final concentration of 1 µM for 1 week or solvent, 
respectively. After incubation, the reaction was stopped by placing the tubes in liquid nitrogen (for 
Western blots) or with ice-cold PBS-azide (for microscopy) (Bartis, Boldizsar et al. 2006). 4 week-
old BALB/c mice were used for the experiments. Animals received a single dose (20 mg/kg) 
Dexamethasone (DX, Oradexon, Organon) injection intraperitoneally (i.p.) in PBS, then were 
sacrificed 24 and 168 hours after injection (control animals received PBS). Another group of mice 
received PBS and DX for 3 months, respectively. There was also a group of mice receiving once 
high dose DX, then continuously low dose DX (2 mg/kg) in every second day for a month, to 
mimic the therapeutic regimen of autoimmune diseases (Buttgereit, da Silva et al. 2002; Buttgereit, 
Straub et al. 2004) 
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5.4 Manipulation of gene expression 
 
5.4.1. Retroviral Constructs 
 
Wnt4: The Wnt4 sequence was purchased and subcloned from an Origene (Origene) vector 
containing human full-length Wnt4 cDNA.  
 
LAP2α: The full-length murine LAP2α cDNA containing plasmid was a kind gift of Dr. Simon 
Amos (Institute of Haematology, Chaim Sheba Medical Center, Tel-Hashomer, Israel) 
 
PKCδ: PKCδ sequence in a pHACE vector was a kind gift of Dr. Jae-Won Soh, Professor of 
Biochemistry at Inha University, Korea. 
 
The GFP (mock), LAP2α or Wnt4 over-expressing TEP1 cell lines were generated using retroviral 
vectors that were prepared as described previously (Kvell, Nguyen et al. 2005).  
Wnt4 and PKCδ sequences were amplified and cloned into the MIGRI retroviral vector ( a kind gift 
from W.S. Pear, Department of Pathology and Laboratory Medicine, University of Pennsylvania, 
PA). Retrovirus was produced by transfecting the plasmid DNA into the Phoenix packageing cell 
line (American Type Cell Culture Collection) using Lipofectamine 2000 (Invitrogen). 
 
5.4.2. Transient transfection of siRNA PKCδ 
 
 siRNA specific for PKCδ was purchased from Santa Cruz. TEP1 cells were grown to 80% 
confluency then siRNA and control siRNA was delivered using Lipofectamine according to 
manufacturer’s recommendation. PKCδ mRNA levels were monitored by qRT-PCR prior Wnt 
treatment. 
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5.5. Detection of gene transcription 
 
5.5.1. cDNA generation 
 
cDNA was generated both from cell lines and primary cells by isolating total RNA either by TRI-
reagent (MRC) or by using an RNA isolating kit (Macherey Nagel). DNA contamination was 
eliminated by a DNA digestion step using RNase free DNaseI. cDNA was made using the high 
capacity RNA to cDNA kit (Life Technologies Inc.). Reverse transcription of 0.5 µg of total RNA 
was performed in 50 µl total volume using random hexamer primers. 
 
5.5.2. Standard Reverse Transcription Polymerase Chain Reaction 
(RT-PCR)  
 
RT-PCR was conducted using Reddymix (ABgene) master mix solution and target sequence 
specific primer pairs as described previously (Moore, Anderson et al. 1993). Samples were matched 
for β-actin to ensure equal cDNA loading. Primer sequences used in PCR reactions are summarized 
in Table1 (p. 28.). 
 
5.5.3. Microarray analysis 
 
Microarray Sample Preparation, Hybridization, and Image Analysis - Starting with 100 ng of 
poly(A)+ RNA, one round of RNA amplification was performed with the MessageAmp aRNA 
amplification kit (Ambion) using a 4:1 amino-allyl UTP: UTP ratio for aRNA incorporation. For 
each sample, 8 µg of aRNA was coupled to N-hydroxysuccinimidyl esters of cyanine-3 or cyanine-
5 (Amersham Biosciences). Following a clean up step, treated and untreated aRNA samples with 
opposing cyanine labels were combined, concentrated, and treated with a fragmentation  reagent 
(Ambion) according to the manufacturer's protocol. For each slide, 4 µg of both treated and 
untreated cyanine-labelled aRNA samples were combined with a hybridization buffer (2.3x SSC, 18 
mM HEPES, 0.2 mg/ml bovine serum albumin, 0.6 mg/ml poly(A), 0.2% SDS), heat-denatured for 
3 min at 95 °C, and applied to microarrays under a LifterSlip coverslip (Erie Scientific). The slides 
were placed in a hybridization chamber (Dietech) and incubated in a 63 °C water bath for 16 h. 
Following hybridization, the slides were successively washed in 0.6x SSC with 0.025% SDS, 0.05x 
SSC, and water then dried. The microarrays were scanned with an Axon 4000B scanner and 
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adaptive spot segmentation performed with GenePix Pro software (version 5.0) (Axon Instruments). 
For each treated sample, three independent replicate microarray experiments were performed.  
Microarray Data Analysis - Triplicate dye-swap, background-subtracted median intensity values 
were used as input to the LIMMA analysis package in Bioconductor (Gentleman RC, Carey VJ et 
al. 2004), and average LOESS-corrected log2 ratios were used to estimate differential gene 
expression. Microarray and microarray data analysis was performed by the Center for Genomics, 
University of Debrecen, Hungary. 
 
5.5.4. Real-time qRT-PCR 
 
Using SYBR Green PCR master mix in reagents and 100 nM sequence specific  primers (Table 1) , 
PCR  reactions were set up in the ABI Prism 7900HT sequence detection system.( 95 °C incubation 
for 10 min, then 40 cycles (95 °C/15 s; 60 °C/1 min)). Threshold cycles (CT) for three replicate 
reactions were determined using Sequence Detection System software (version 2.2.2), and relative 
transcript abundance was calculated following normalization with a β-actin PCR amplicon. 
Amplification of only a single species was verified by a dissociation curve for each reaction.  
 
5.6. Cell sorting 
 
TEP1 cells were infected with recombinant retroviruses containing MIG-WT- PKCδ-GFP or Wnt4-
GFP and cells were sorted based on GFP expression by FACSVantage Cell Sorter (BD). Sorted 
cells were collected for mRNA and protein extraction, microarray, qRT-PCR and Western-blot 
analysis.  
 
5.7. PKCδ activation assay 
 
Cells were lysed in RIPA buffer (Sigma–Aldrich) supplemented with protease, and phosphatase 
inhibitors (Sigma–Aldrich) and immunoprecipitated with rabbit anti-PKCδ (658-676) pAb Lot# 
D28896 (Calbiochem) and protein-G resin (Sigma–Aldrich) overnight at 4oC. The kinase assay was 
performed using the HTScan Kinase –assay Kit (Cell Signaling Technology Inc.) using a 
biotinylated substrate peptide in the presence of PKCδ diluted in kinase buffer (25 mM Tris-HCl 
pH 7.5 containing 10 mM MgCl2, 0.1 µM Na3VO4, 5 µM β-glycerophosphate, 2 µM dithiothreitol 
(DTT)). Active PKCδ kinase GST fusion protein (162ng/µl (54ng/well) was supplied to the kit as 
positive control. PKCδ specific activity was quantified in a colorimetric ELISA Assay using 96-
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well streptavidin-coated plates (Lot# 70850 (Institute of Isotopes, Budapest, Hungary, Soft Flow 
Hungary Kft. Pecs, Hungary). Phosphorylation level of biotinylated substrates from each kinase 
reaction mixes were measured using a rabbit anti-phospho-antibody (1:1000) detected by a HRP-
labelled anti-rabbit (1:1000) secondary antibody (both antibodies provided with the kit) in the 
presence of 3,3’,5,5’-tetramethylbenzidine (TMB) substrate. The optical density (absorbance) was 
read in an iEMS Reader MF V2.9 (Thermo Scientific) spectrophotometer using a bi-chromatic 
measurement system at 450nm and using 620 nm as reference.  
 
5.8. Purification of proteins from cell membrane and cytosol 
 
TEP1 cells were treated with Wnt4 containing SN-s (supernatants) for 5 minutes. Wnt4 treated cells 
as well as the Wnt4 over-expressing cell line were pelletted at 10000g for 1 min at 4 oC and 
resuspended in 500µl of ice cold buffer H (20 mM Tris pH 7,5 containing 0,25 M Sucrose, 10 mM 
DTT, 2 mM EDTA, 2 mM EGTA) supplemented with PMSF (1nM) and Leupeptin (100 µg/ml). 
Samples were sonicated on ice three times for 10 sec-s and pelletted (30 000g, 30min, 4oC). 
Supernatants containing the cytosolic fraction were kept at -80 oC until used. Pellets were 
resuspended in 375 µl of ice cold buffer H supplemented with PMSF (1nM), Leupeptin (100 µg/ml) 
and 0,5% of Triton X-100 then vortexed. Samples were incubated on ice for 10 min then 
centrifuged at 30000g for 10min at 4oC for collecting membrane proteins. Proteins of cytosolic and 
membrane fractions were separated on 10% SDS PAGE and PKCδ protein was detected using 
Western blotting.  
 
5.9. Immuno-precipitation 
 
 TEP1 cells were lysed in RIPA-buffer (Sigma–Aldrich)  supplemented with protease, and 
phosphatase inhibitors (Sigma–Aldrich) then anti-Fz-6 or anti-Fz-4 Abs and protein G resin 
(Sigma–Aldrich) were added to the protein mix and incubated overnight at 4oC Resins were then 
pelleted, washed and prepared for  western blotting.  
 
5.10. Western blotting 
 
TEP1 cells were collected (2000rpm, 5 min, 4oC) and lysed in RIPA-buffer containing a 
Phosphatase Inhibitor Cocktail (Sigma-Aldrich) and RQ1 RNase free DNase (Promega). 
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After adding equal amount of 2× sample buffer (125mM Tris, 4% SDS, 10% glycerol, 0.006% 
Bromo-phenol-blue and 10% mercapto-ethanol), whole cell lysates were resolved in 10% SDS–
PAGE. Gels were blotted onto nitrocellulose membranes using BioRad MiniProtean electrophoresis 
equipment (Bio-Rad), then blocked in TBS-T buffer (10mM Tris, pH 7.4, 100mM NaCl and 0.1% 
Tween 20) containing 3% fat-free dried milk. Membranes were then incubated in primary Ab 
(1:1000 dilution) for 2 h at room temperature, then washed three times in TBS-T and incubated in 
secondary Ab of HRP-conjugated donkey anti-rabbit Ig (1:1000 dilution). Proteins were visualised 
by enhanced chemiluminescence as described in the manufacturer’s instructions (SuperSignal West 
Pico Chemiluminescent substrate (Pierce) and analysed by Fuji LAS4000 image station using 
different exposure times from 0.5 – 6 min for best quality. 
 
5.11. Immuno-histochemistry 
 
Frozen thymic sections (7-10 µm thick) were fixed in cold acetone or in 4% paraformaldehyde, then 
dried and blocked using 5% bovine serum albumin (BSA in PBS for 20 min) before staining with 
the appropriate antibodies for 30 min at RT. For histology fluorescent antibodies were used as 
described previously. The sections were analyzed by an Olympus Fluoview 300 confocal 
microscope with an Olympus Fluoview FV1000S-IX81 system or an Olympus BX61 microscope 
equipped with CCD-camera and AnalySIS software.  
 
5.12. Statistical analysis 
 
All experiments were performed minimum three separate occasions. Where appropriate, 
representative experiments or images are shown or Student t-test was performed and data are 
presented as mean ± 1 SD by error bars. Asterixes represent significant changes with (*p<0.05) 
unless otherwise mentioned.   
 
 28
Table 1. List of PCR primers 
 
Gene Forward primer Reverse primer 
β-actin TGG CGC TTT TGA CTC AGG A  GGG AGG GTG AGG GAC TTC C 
Wnt4 cloning 
primers 
gaagatcttc 
ATGAGTCCCCGCTCGTGC 
ccgctcgagcgg 
TCATCGGCACGTGTGCAA 
Wnt4 PCR 
primers 
CTC AAA GGC CTG ATC CAG AG TCA CAG CCA CAC TTC TCC AG 
CTGF GGCCTCTTCTGCGATTTCG CCATCTTTGGCAGTGCACACT 
PKCδ AGGCCGTGTTATCCAGATTG CGGTTCATGGTTGGAAACTT 
Fz-4 TCTGCTTCATCTCCACCACCTT GCGCTCAGGGTAAGAAAACCT 
Fz-6 GCGGCGTTTGCTTCGTT CACAGAGGCAGAAGGACGAAGT 
LAP2α TGA ACT GCA GGC AGC TAA GA TCA TAG CTA GAC TCT GAG G 
Lamin1 TGA GTA CAA CCT GCG CTC AC TGA CTA GGT TGT CCC CGA AG 
PPARγ CCC AAT GGT TGC TGA TTA CAA A AAT AAT AAG GTG GAG ATG 
CAG GTT CT 
ADRP CGC CAT CGG ACA CTT CCT TA GTG ATG GCA GGC GAC ATC T 
E-cadherin AAG TGA CCG ATG ATG ATG CC CTT CAT TCA CGT CTA CCA CGT 
N-cadherin GTG GAG GCT TCT GGT GAA AT CTG CTG GCT CGC TGC TT 
FoxN1 Applied Biosystems TaqMan probe 
PN4351272 (Mm00477457_m1) 
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6. Results 
 
Summary of Results 
 
I. Physiological thymic senescence 
 
1. The mouse thymus undergoes morphological changes 
2.  Wnt4 is down-regulated while LAP2α is up-regulated during the process 
3. Adipose involution is regulated by LAP2α, ADRP and PPARγ 
4. Adipose involution is preceded by EMT marked by E-cadherin down-regulation 
5. Wnt4 can reduce the expression of genes responsible for adipocyte-type trans-differentiation 
6. Wnt4 receptors that transduce β-catenin pathway activator (Fz-4) and inhibitor (Fz-6) 
signals are up-regulated at early stages of senescence 
7. PKCδ is activated by Wnt4 signals 
8. PKCδ associates with both receptors but preferentially with Fz-6 
9. Wnt4 target gene CTGF and one of its receptors, Fz8 are involved in a negative feedback 
loop regulating the canonical Wnt pathway 
 
 
II. Steroid induced thymic senescence 
 
1. Similarly to physiological senescence, Wnt4 is down-regulated while LAP2α is up-regulated 
during DX induced thymic involution 
 
2. Wnt4 can protect against DX induced adipoid trans-differentiation 
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6.1. Physiological thymic senescence 
 
6.1.1. Disintegration of the epithelial network 
 
Senescence exhibits characteristic histological changes in both the human and mouse thymus 
(Oksanen 1971; Marinova 2005). In order to demonstrate this process in mice, thymic lobes of 1 
month and 1 year old BALB/c mice were analyzed. In young adult mice, histology revealed strict 
segregation of epithelial cell compartments by staining for medullary (EpCAM1++, Ly51-) and 
cortical (EpCAM1+, Ly51++) epithelial cellular subsets. Thymic morphology shows high level of 
integrity just preceding puberty/early adulthood (Fig. 6).  However, the highly organized structure 
disintegrates and becomes chaotic by the age of 1 year. By this age the previously shown strict 
cortico-medullary delineation becomes disintegrated, degenerative vacuoles appear surrounded by 
areas showing strong co-staining with both epithelial markers. There are also other large cellular 
areas that lack staining with either epithelial markers, a pattern completely absent at the young adult 
age. Staining of extracellular matrix components of fibroblast origin (ER-TR7++) on cryostate 
thymic sections of 2 month and 9 month old BALB/c mice were performed to identify epithelial and 
mesenchymal elements in young adult and ageing thymic lobes. The above ages were selected to 
check additional time points and more precisely map the timeframe of thymic physiological 
senescence. The staining patterns are strikingly different at the two ages examined. In the 2 month 
old thymic tissue section, anti-EpCAM1 and anti-ER-TR7- show little tendency for co-localization. 
In stark contrast, by the age of 9 months anti-EpCAM1 and ER-TR7-staining show significant 
overlap within the thymic medulla, a phenomenon completely absent at earlier ages.   
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Figure 6. Disintegration of the epithelial network 
Figure 6A demonstrates a cryostat section of 1 month, whereas figure 6B presents cryostat section of 1 year old 
BALB/c mouse thymus. Staining pattern: anti-EpCAM1-FITC (green), anti-Ly51-PE (red), DAPI (blue). ‘M’ marks 
medullary (EpCAM1++, Ly51-), while ‘C’ marks cortical (EpCAM1+, Ly51++) epithelial compartments on Figure 6A. 
Single asterisk (*) marks degenerative vacuoles, while double asterisk (**) mark the loss of epithelial staining on Figure 
6B. Figure 6C (lower left) shows cryostate section of 2 month, whereas figure 6D (lower right) demonstrates cryostate 
section of 9 month old BALB/c mouse thymus. Staining pattern: anti-EpCAM1-FITC (green), anti-ER-TR7-PE (red), 
DAPI (blue). The EpCAM1++ thymic medulla is outlined by continuous line on Figures 6C and 6D for easier 
visualization. 
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6.1.2. Adipose involution 
 
To demonstrate how the disorganization of thymic epithelial network is followed by the emergence 
of adipocytes, thymic sections of 1.5 year old GFP-transgenic BALB/c mice were analyzed. This 
mouse strain develops and reproduces exactly like control BALB/c mice, and the thymic epithelial 
function and thymocyte maturation is indistinguishable from wild type controls (Kvell, Czompoly 
et al.). However, due to the ubiquitous and strong EF1 promoter-driven transgene transcription, 
bright GFP expression offers a native, green-coloured, cytoplasmic staining for all the cells in these 
mice. Thymic sections of senescent GFP-transgenic mice were co-stained with LipidTox Red  to 
identify adipocytes. Histology shows the presence of relatively large, inflated cells in which the 
green-coloured (GFP-containing) cytoplasm is pushed to the periphery by red-staining neutral lipid 
deposits, a pattern characteristic of adipose cells (Fig. 7).  
 
 
 
Figure 7. Adipose involution 
Figure 7. shows adipose involution over cryostat section of 1.5 year old GFP-transgenic BALB/c mouse thymus. 
Staining pattern: GFP (green), LipidTox Red  (red). 
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6.1.3. Gene expression changes in the thymic epithelium during ageing 
 
To investigate the underlying molecular events of thymic epithelial senescence, gene expression 
changes were investigated in TECs purified from 1 month and 1 year old BALB/c mice based on 
EpCAM1 expression (MACS separation). Following cDNA synthesis, quantitative RT-PCR 
analysis was performed. Several genes including Wnt4, FoxN1, PPARγ, ADRP, lamin1 and LAP2α 
were tested.  The expression of both Wnt4 and FoxN1 decreases in thymic epithelial cells. Highly 
decreased level (or total absence in some cases) of FoxN1 could be the consequence of strong Wnt4 
down-regulation by the age of 1 year, indicating that TECs can down-regulate FoxN1 expression 
while maintaining that of epithelial cell surface markers like EpCAM1 (Balciunaite, Keller et al. 
2002). At the same time, mRNA levels of pre-adipocyte differentiation markers PPARγ and ADRP 
rise with age in the same, EpCAM1-positive cell population. This finding is in harmony with 
histological data demonstrating the emergence of adipocytes in the thymic lobes of senescent mice. 
The expression of lamin1, a key component of the nuclear lamina remains unaffected during 
senescence in thymic epithelial cells; whereas, the expression of LAP2α increases significantly. 
This degree of dissociation between lamin1 and LAP2α expression is of note and suggests 
functional differences despite conventionally anticipated association of lamin1 and LAP2 molecular 
family members. The measured LAP2α up-regulation associated with age-related adipose 
involution is, however, in perfect agreement with other literature data suggesting the pre-adipocyte 
differentiation-promoting effect of LAP2α in fibroblasts (Dorner, Vlcek et al. 2006). The first report 
to show that such, normally fibroblast associated molecular changes occur in purified TECs was 
first performed in our laboratory.  
As in the literature, epithelial mesenchymal transition (EMT) is associated with differential 
expression of E- (decrease) and N-cadherin (increase) (Seike, Mizutani et al. 2009). TECs were 
tested for these markers to investigate whether the first step towards pre-adipocyte differentiation is 
the EMT of epithelial cells. In purified TECs while E-cadherin mRNA levels significantly 
decreased, N-cadherin gene expression showed a slight increase during ageing, indicating that EMT 
might be the initial step in epithelial cell transition to become pre-adipocytes (Fig. 8). 
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Figure 8. Molecular changes in thymic epithelium 
Figures 8A–D demonstrate gene expression changes of MACS purified thymic epithelial cells measured by qRT-PCR. 
Please note that the Y-axis scale is logarithmic. 
 
 
6.1.4. Studies of LAP2α and Wnt4 effects on TEC  
 
To study the hypothesis that both LAP2α and Wnt4 play important but opposite roles in thymic 
senescence, stable LAP2α over-expressing or Wnt4-secreting transgenic TEP1 cell lines were 
established using lentiviral transgenesis. The use of a primary-derived model cell line provides the 
advantage of absolute purity, the complete lack of other cell types that could potentially affect the 
gene expression profile of epithelial cells (Beardsley, Pierschbacher et al. 1983). The established 
transgenic cell lines proliferated normally and did not show obvious signs of phenotypic changes 
(data not shown). In contrast to morphology, quantitative RT-PCR analysis revealed that LAP2α 
over-expression triggers an immense surge of PPARγ expression (Fig. 9). Such an increase in 
mRNA level suggests that this is not a plain quantitative, but rather a qualitative change. ADRP a 
direct target gene of PPARγ was also up-regulated although to a lesser extent. On the other hand in 
Wnt4-secreting TEP1 cells the mRNA level of both PPARγ and ADRP was decreased (Fig. 9). In 
the TEP1 cell line the expression of FoxN1 could not be addressed as it was very low and 
consequently undetectable (data not shown). 
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Figure 9. Gene expressions in stable LAP2α and Wnt4 over-expressing cell lines 
Gene expression changes of LAP2α and Wnt4 over-expressing transgenic TEP1 cells measured by qRT-PCR. The Y-
axis scale is logarithmic. 
 
6.1.5. Fz-4 and Fz-6 levels are affected by age  
 
Once the preventive role of Wnt4 was established in adipocyte-type trans-differentiation of TECs, 
receptor associated signalling studies have ensued to investigate what signal modifications can lead 
to Wnt4 effects. Initially, expression levels of Wnt4 receptors, Fz-4 and Fz-6 were analysed in 
thymi of 1 month and 9 month old Balb/c mice. qRT-PCR analysis of purified EpCAM1+ TECs 
showed increased expression of both Fz-4 and Fz-6 mRNA (Fig. 10A and B) by 9 months of age. 
Immuno-histochemistry using Fz-4 and Fz-6 specific antibodies confirmed elevated levels of both 
receptor proteins (Fig. 11A-D). Additionally, differential expression pattern of Fz-4 and Fz-6 was 
also observed in the thymic medulla and cortex. While in the young thymus the medulla 
(EpCAM1++/Ly51-) was strongly stained for Fz-4 and Fz-6, the cortex (EpCAM1+/Ly51+) only 
faintly stained for these receptors. In the 9 month old thymus the medulla is less pronounced and in 
contrast to the young tissue, the whole section including the cortex became increasingly positive for 
both receptors. 
  
  
 
 
 
 
Figure 10. Fz-4 and Fz-6 expression during thymic senescence.
(A, B) QRT-PCR analysis of Fz-4 and Fz
epithelium. Data was normalised to β-actin.
 
A. 
  
-6 expression in young (1month) and ageing (9 months) mouse thymic 
 
B. 
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Figure 11. Changes in Frizzled receptor expression pattern during ageing 
B. 
A. 
C. 
D. 
 Figure 11. Changes in Frizzled receptor expression pattern during ageing (previous page)
Figure 11A-D shows the expression level and staining pattern of Fz
NL663 and anti-Fz-6- NL663 antibodies, respectively. Thymic morphology was displayed 
EpCAM1-FITC and anti-Ly51-PE TEC markers. S
stainings are shown from a minimum of five repeats (bar=100µ
 
6.1.6. Active receptor signalling is indicated by PKC
 
As Wnt4 levels as well as its receptors are modulated during the ageing process, further studies 
were necessary to investigate active recept
level of phosphorylation of receptor associated signalling molecules. As Fz
that are phosphorylated by the 
overexpressing TEP1 cell line was established by retroviral transfection and validated by RT
(Fig. 12A) and western blot analysis (Fig. 12B). 
indicate stabilization of β-catenin that phenomenon is assoc
test the involvement of PKCδ in Wnt4 signal transduction, increased Wnt4 levels were achieved by 
treatment using the supernatant of Wnt4
 
 
 
Figure 12. Generation of Wnt4 over
 (A) RT-PCR analysis of Wnt4 over-expressing transgenic cells compared to mock (GFP) transfected TEP1 cells. (B) 
Verification of Wnt4 functionality by western blot analysis 
analysis of Wnt4 expression in Wnt4-GFP over
significant differences are marked by asterisks.
A. 
C. 
-4 and Fz-6 assayed by histology 
via
ize marker is shown in the corner of the figure. Characteristic 
m). 
δ translocation
or signalling that is invariably associated with modified 
-
δ isoform of PKCs, PKCδ activity was investigated. 
Decreased level of β-catenin phosphorylation 
iated with canonical Wnt signalling. 
-transgenic TEP1 cell line (Fig. 12C). 
 
-expressing TEP1 cell line by retroviral gene transfer
of p-β-catenin and total β-catenin levels. (C) 
-expressing compared to GFP transfected TEP1 cells. 
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 Wild type TEP1 cells were exposed to SNs 
cells for 1 hr, then cytosolic and membrane fractions were isolated from cell lysates. Similarly to 
previous studies with Wnt-5a (Giorgione, Hysell et al. 2003)
within one hour of Wnt4 exposure PKC
the cleavage products (Kanthasamy et al, 2006) characteristic of PKC
Densitometric analysis of total and cleaved PKC
activation upon Wnt4 exposure. Additionally, increased membrane localisation of PKC
detected (39 fold increase) in the Wnt4
 
 
 
 
 
Figure 13. Intracellular translocation of PKCδ
Cytosolic and membrane proteins were separated from control, 
Western blot analysis demonstrated PKC
Ponceau red stained total protein. Representative 
 
 
As for Wnt4 specific receptor expression, both Fz
assumed that active receptor signalling might require more PKC
localisation of PKCδ to the membrane fraction (Fig. 13), up
at both mRNA (Fig.14A) and protein level (Fig.14B and C
characteristic cortico-medullary PKC
PKCδ was preferentially expressed in the cortex (EpCAM1
  
of control (TEP1-GFP) and Wnt4 (TEP1
, Western blot analysis revealed that 
δ translocated into the membrane fraction (Fig. 13) where 
δ activation were detected. 
δ demonstrated a 2 fold increase in PKC
-overexpressing cell line (Fig. 13).  
 during active receptor signalling
Wnt4 treated and Wnt4 overexpressing TEP1 cells. 
δ translocation. Loading controls are shown below the Western blot as 
blots are shown from three repeats. 
-4 and Fz-6 levels increased with age, it was 
δ during ageing. Indeed, apart from 
-regulation of PKC
) in the ageing thymi. 
δ pattern has also emerged. In both young and ageing 
+/Ly51++) (Fig. 14B
39
-Wnt4-GFP) 
δ 
δ was also 
 
 
δ was also detected 
Interestingly, a 
thymi 
 and C).  
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Figure 14. PKCδ expression pattern changes during ageing 
(A) Gene expression of  PKCδ changes with age by qRT-PCR. TECs were purified from young (1 month) and ageing (9 
months) mice. Data were normalized to β-actin housekeeping gene. Statistically significant differences are marked by 
asterisks. (B, C) Age associated changes in PKCδ expression by histology. Cryostate sections of 1 month and 9 months 
old mouse thymi were stained with anti- PKCδ− NL663, anti-EpCAM1-FITC and anti-Ly51-PE.  Characteristic 
stainings are shown from a minimum of five repeats (bar=100µm). 
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6.1.7. Identification of Wnt4 target genes in TECs using microarray 
analysis 
 
To be able to identify molecular interactions within the Wnt4 specific signal transduction process, 
modification of specific signalling molecules became necessary. However, to detect Wnt4 specific 
effects, identification of reliable read-out markers became essential. 
To investigate Wnt4 ligand specific gene activity, TEP1 cells were exposed to Wnt4 enriched 
medium for 1hr after a thorough wash with protein free medium. Microarray analysis of gene 
expression changes identified several genes that were affected by Wnt4 treatment (Table 2).  
 
 
TABLE 2. A selected list of gene expressions modulated by Wnt4  
Gene  Fold change upon Wnt4 exposure 
CTGF 4,31±0,20 
c-Jun 2,15±0,11 
IER2 1,87±0,14 
IER3 2,52±0,17  
ANKRD 2,11±0,10 
LNFR 0,51±0,05 
PHLDA1 4,58±0,22 
SEMA-Domain 0,84±0,05 
 
 
Wnt4 specific effect on gene expression modification was tested by depletion of Wnt4 from the 
medium using a Wnt4 specific antibody (Abcam). The Wnt4 depletion assay demonstrated 
abrogation of increased gene transcription indicating that gene expression changes were triggered 
by Wnt4 (ANKRD: from 2.1 times induction to 1.5 times, c-jun: from 2.5 times induction to 1.2 
times etc.).  
Since connecting tissue growth factor (CTGF) showed significant and reliable regulatory pattern in 
the experimental system, it was chosen as a read-out gene in Wnt4 signalling studies. To 
investigate, whether CTGF is only an immediate early gene following Wnt4 exposure or its 
expression is prolonged in a Wnt4 rich environment, gene expression profile of the Wnt4 over-
expressing cell line was studied (Fig. 15). As CTGF transcript was detectable above control levels, 
CTGF was deemed suitable as a read-out gene for signalling studies during ageing.  
  
 
 
Figure 15. Analysis of Wnt4 target gene (CTGF) expression
QRT-PCR analysis of CTGF expression in control, Wnt 4
significant differences are marked by asterisks.
 
 
6.1.8. PKCδ in Wnt4 signalling
To investigate PKCδ involvement in Wnt4 signalling, PKC
expression of wild type PKCδ (Fig. 16
available siPKCδ (Santa Cruz) (Fig. 1
TEP1 cells with increased or decreased PKC
1 hr, and then CTGF expression was analysed (Fig. 17A
 
 
-treated, Wnt4 over-expressing TEP
  
 
δ activity was 
A-C) or by silencing PKCδ translation using commercially 
6D).   CTGF was used as a read-out gene in the experiments. 
δ levels were exposed to control and Wnt4 rich SNs for 
-B). 
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1 cells. Statistically 
modified by over-
       
Figure 16. Gene-expression levels of PKCδ
 (A) PKCδ expression by qRT-PCR in control and PKC
blot using control and PKCδ overexpressing 
assay, relative absorbance values of controls, GFP only and PKC
RNAi silencing measured by qRT-PCR 
significant differences are marked by asterisks.
A. 
B. 
C. 
D. 
 
 
 
 in over-expressing and silenced TEP1 cell line
δ over-expressing TEP1 cells. (B) PKC
TEP1 cells. (C) PKCδ activity was also measured by colorimetric ELISA 
δ over-expressing cells are shown. (D) 
in mock and PKCδ specific siRNA-transfected TEP1 cells.
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δ expression by Western 
PKCδ specific 
 Statistically 
  
Figure 17. CTGF expression changes in Wnt4 signalling in TEP1 cell lines
(A) qRT-PCR analysis of CTGF expression in control and Wnt4 treated PKC
qRT-PCR analysis of CTGF expression in
were normalized to β-actin. Statistically significant differences are marked by asterisks.
 
Surprisingly, although over-expression of PKC
transcription (Fig. 17A), even moderate down
CTGF expression in the presence of Wnt4 (Fig. 17B), indicating that PKC
negative regulatory loop.  
A. 
B. 
 
 
δ over-expressing TEP
 control and Wnt4 treated in TEP1 cell lines pre-treated with si
 
δ had no radical effect on Wnt4 target gene 
-regulation of PKCδ was able to significantly increase 
δ might be involved 
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1 cell line. (B) 
PKCδ. Data 
in a 
 6.1.9. Co-immuno-precipitation of PKC
 
As Fz-6 has been implicated in previous studies as a negative regulator of 
signalling, it was important to determine whether PKC
Wnt4 receptors. Co-immuno-precipitation patterns of PKCδ
control and Wnt4 SN treated cells revealing association of PKC
with both Fz-4 (1.2 fold, 2 fold and 1.4 fold, respectively) and Fz
detectable over non-detectable, respectively) upon Wnt4 treatment (Fig. 1
 
 
 
 
 
Figure 18. Analysis of Fz-4, Fz-
 (A, B) Western blot analysis following 
increased association of Fz-6 with PKCδ
repeats.  
 
 
To find out whether PKCδ co-localises with Fz
was performed. Experiments demonstrated age dependent increase of both Fz
as co-localisation of Fz-6 and PKC
and PKCδ co-localisation is more pronounced in the thymic cortex (Fig. 1
it is the medulla that exhibits stronger staining for both proteins (Fig. 1
A. 
δ with Dvl, Fz-4 and Fz
δ is preferentially associated with either 
 with Fz-4 and Fz
δ and its active cleavage products 
-6 (1.4 fold, 1.5 fold and strongly 
8A and 
 
6, Dvl and PKCδ co-localisation 
immuno-precipitation using a-Fz-6-antibody (A) or a-
 and Dvl upon Wnt4 treatment. Representative blots are shown from two 
-6 in primary thymic tissue, immuno
δ staining (Fig. 19A and B). While in the young thy
9A), in the ageing thymus 
9B).  
B. 
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-histochemistry 
-6 and PKCδ  as well 
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Figure 19. Immuno-histochemical analysis of Fz-6 and PKCδ co-localisation 
(A, B) Histology of 1 month and 9 months old mouse thymi using anti-PKCδ− NL663, anti-Fz-6-NL557 and anti-
EpCAM1-FITC antibodies. Size markers are shown in the corner of all histology figures. Characteristic stainings are 
shown from a minimum of five repeats (bar=150µm). 
A. 
B. 
 6.1.10. Increased expression of CTGF and Fz
 
While increased expression and activity of the Fz
signalling pathway explains some aspects of uneven target gene transcription following 
manipulation of PKCδ activity, parallel changes like up
that might add to the complexity of the signalling process. Increase in Fz
correlated with increased CTGF gene expression (Fig.
If Fz-6 that also increases during senescence is truly a suppressor of 
CTGF expression should have decreased or remained unchanged as Fz
have been quenched by Fz-6 signalling. To test the above hypothesis, we have considered the 
following: CTGF has recently been reported to
blocking β-catenin stabilisation 
degradation of β-catenin (Luo, Kang et al. 2004)
feed-back loop. As CTGF is a secreted protein, expression of Fz
recently reported receptor for CTGF was analysed in purified TECs of 1 and 9 months old thymi 
using qRT-PCR. As parallel with CTGF, Fz
while the direct target of β-catenin dependent Wnt4 
FoxN1became undetectable (data no
additional negative feed-back loop.
 
 
Figure 20. CTGF and Fz8 expression during thymic senescence
(A, B) qRT-PCR analysis of CTGF and Fz
epithelium. Data was normalised to β-actin. Statistically significant differences are marked by asterisks. 
A. 
-8 
-6 receptor, a suppressor of the canonical Wnt 
-regulation of Fz-4 also occur during ageing 
-4 levels in a
 20A).  
β-catenin signalling then 
-4 transmitted signals would 
 negatively regulate canonical Wnt signalling by 
via GSK3β activation leading to phosphorylation and consequent 
, indicating that CTGF might be part of a negative 
-8 (Mercurio, Latinkic et al. 2004)
-8 mRNA levels increased (Fig. 
signalling (Balciunaite et al., 2002) 
t shown) (Kvell et al., 2010), indicating the existence of an 
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 6.2. Steroid induced thymic senescence
 
A commonly held view is that the
studies showing that growth hormone (GH) and sex steroids can 
the thymus and that their concentrations change with age 
2006), GH and insulin-like growth factor
et al. 1999) and their production declines with age. However, it is the increased production of sex 
steroids at puberty that is most often associated with thymic involution.
thesis describes mechanisms associated physiological thymic senescence. As steroids are frequently 
applied medications, investigations were extended to identify similarities in induced and 
physiological senescence and potential mechanisms that mi
of the thymus. 
 
6.2.1. Effects of single-dose GC administration
 
Similarly to physiological senescence, the level of both FoxN1 the transcription factor essential for 
thymic organogenesis and maintenance and its reg
24 hrs following a single dose DX  injection and remained at low levels over 1 week (Fig. 2
 
 
Figure 21. Dexamethasone (DX)
Wnt4 (A) and FoxN1 (B) expressions in 
Gray bars represent gene expressions 168 h after DX treatment and asterisks indicate significant differences
 
Down-regulation of FoxN1 and Wnt4 correlated wit
LAP2α and PPARγ (Fig. 22), indicating 
senescence. 
A. 
 
 thymus involutes at puberty, and this model is based primarily on 
affect 
(Min, Montecino
-I (IGF-I) as well have thymopoietic effects
 The previous par
ght be able to reduce adipoid involution 
 
ulator Wnt4 decreased in EpCAM1
-induced effects on Wnt4 and FoxN1 expressions 
DX-treated thymic epithelial cells (TEC) control (
h up-regulation of pre
further molecular similarities with physiological 
B. 
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Figure 22. Dexamethasone (DX)
Expression of LAP2α (A) and PPARγ (B) 
elevated in DX-treated samples (black) compared to control
Results are representative of three independent 
 
 
6.2.2. Effects of sustained GC administration
 
In clinical treatments GC analogues are widely used for extended periods of time. To mimic this 
pattern of clinical application, mice were injected with DX repeatedly for a time course of 1 
Both Wnt4 and FoxN1 levels were drastically down
while the adipocyte differentiation fact
significantly increased by this advanced time point (Fig. 2
type trans-differentiation is completed over a time period where the early trigger signal is an 
increase in LAP2α expression that is followed by PPARγ
 
 
A. 
-induced effects on expressions of LAP2α
were tested in TECs 168 h after a single DX injection and were found to be 
 (white). Gene expression was normalized t
experiments. 
 
-regulated measured by 
or ADRP, down-stream target of LAP2α γ
3). The results indicated that adipocyte
, then ADRP up-regulation.
B. 
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 and PPARγ 
o 18S rRNA. 
month. 
qRT-PCR (Fig. 23), 
 and PPAR  was 
-
 
  
Figure 23. Effect of sustained DX 
Wnt4, FoxN1, LAP2α, PPARγ, and ADRP expression of control and DX
and LAP2α were found to be reduced after repeated 
ADRP was found to be elevated in DX-
 
 
6.2.3. Wnt4-mediated inhibition of steroid
differentiation 
 
To test whether Wnt4 can prevent adipocyte
cell line was exposed to solvent or DX for a week then gene expressions were analysed compared 
with control TEP1 cell line.  While in the control cell line DX exposure induced up
adipoid trans-differentiation markers, within the Wnt4 over
trans-differentiation markers were up
against adipoid trans-differentiation. 
As the TEP1 cell line does not ex
the absence of Wnt4 alone is sufficient to allow pre
apparently FoxN1 has no significant role in the process.
 
  
administration (1 month) on TEC gene expressions
-treated TECs. The levels of Wnt4, FoxN
in vivo DX injections, whereas PPARγ was unaltered.
treated samples. Note the scale differences for gene expression.
-induced adipose trans
-type trans-differentiation, Wnt4 overexpressing TEP1 
-expressing cell line, none of the adipoid 
-regulated (Fig. 24) indicating that Wnt4 can protect TECs 
 
press FoxN1 (unpublished observation), it has become evident that 
-adipocyte-type trans
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 Figure 24. Wnt4 overexpression re
TEP1 cells 
Gene expression changes in Wnt4 over-
and ADRP expressions of solvent and DX
indicate solvent-treated control and black bars show the values of DX
three independent experiments. Note the different scales for gene expression.
scues the DX-induced adipocyte-related gene expressions in 
expressing TEP1 - cell line following 168 h of DX-treatment. LAP2
-treated control and Wnt4 over-expressing TEP1 cell lines. 
-treated samples. Results are representative of 
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7. Discussion 
Wnts are involved in many cellular mechanisms in various organs including the thymus. Wnt4 is 
expressed abundantly in the thymus and regulates cell-cell interactions, migration, proliferation, and 
activates different target gene expressions during thymic organogenesis and physiological function 
of the developed thymus. The sequence of Wnt4 is highly conserved in mammals and shows 
multiple roles in organogenesis and homeostasis as well as differentiation. While Wnt4 can elicit its 
effects via the non-canonical signalling network, within the thymus Wnt4 has been regarded as the 
canonical - β-catenin signalling – pathway activator. As Wnts in general and Wnt4 in particular are 
regulators of both thymocyte development and maintenance of TEC identity, the question has risen 
naturally, what role Wnts have in regulating thymic senescence? 
 
The model system was chosen carefully, as rodent tissues do not necessarily mimic age associated 
alterations in human beings. Based on our immuno-histochemical analysis of thymic tissues in 
ageing mice, our experiments provided evidence that in mice the thymic structure becomes just as 
disorganized with age as it does in the human tissue. The border of medullary and cortical area 
becomes less defined and the medullary region occupies less space. Using GFP transgenic animals 
and adipose tissue staining, the mechanism was proved to be highly similar to adipose involution 
that is normally detected in ageing human thymi. 
 
Molecular analysis of ageing thymic tissue revealed that morphological changes were associated 
with down-regulation of Wnt4 and up-regulation of molecules (LAP2α, PPARγ and ADRP) 
responsible for adipoid trans-differentiation. To be able to determine whether TECs can directly 
change into adipocytes or they turn into fibroblasts first, a simple immuno-fluorescent staining 
experiment was performed, where co-localization of the epithelial marker EpCAM1 and the 
fibroblast marker ER-TR-7 was detected indicating gradual changes during the trans-differentiation 
process. Our experiments have provided evidence that adipocytes do not migrate into the thymus 
from perithymic area during ageing, instead they are produced locally via multiple cellular trans-
differentiation steps. 
 
In summary, dedifferentiation of TECs triggers EMT first, then the resulting fibroblasts undergo the 
conventional route of differentiation program towards adipocyte-lineage commitment regulated by 
the continually changing ratio of Wnt4 and LAP2α. Our current understanding of the adipoid 
involution process is summarized in figure 25. 
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Figure 25. Model of adipose involution in thymic ageing 
 
Interestingly, GCs induce similar molecular changes observed during physiological senescence and 
also lead to adipose involution. Wnt4 plays a central role in the involution process, as loss of TEC 
identity and adipose trans-differentiation are tightly associated with decreasing Wnt4 and FoxN1 
levels. As the involution process can be reversed and TEC identity restored by the up-regulation or 
added Wnt4, these results highlighted the regulatory role of Wnt signalling in thymic involution. 
While the physiological model is important, the question remains: what signals trigger down-
regulation of the β-catenin dependent Wnt pathway in such a forceful way that allows the initiation 
of thymic involution? 
 
Signalling studies using cloned Wnt4 have ensued with determination of Wnt4 specific target genes 
to provide a reliable read-out system. Modification of signalling molecules associated with Wnt4 
signals transmitted from Fz-4 and Fz-6 receptors became the target of the investigation. It has 
become evident that PKCδ is involved in signal transduction from both receptors and that PKCδ 
preferentially associates with Fz-6, a negative regulator of β-catenin dependent signalling. 
Additionally, our studies have revealed that down-regulation of β-catenin dependent Wnt signalling 
is progressively down-regulated during ageing via activation of multiple negative feed-back loops 
in the following steps: During the ageing process, Wnt4 levels decrease, while receptor expression 
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increase with proportionally higher expression of Fz-6. The β-catenin dependent Fz-4 signals lead 
to increased expression of CTGF, a β-catenin dependent target gene that is also part of a negative-
feedback loop. CTGF receptor Fz-8 is also up-regulated leading to enhanced activation of GSK3β 
that phosphorylates β-catenin accelerating proteosomal β-catenin degradation in the cytosol. All 
these signalling events lead to FoxN1 down-regulation, loss of TEC characteristics and provide an 
opening for molecular events leading up to adipocyte type trans-differentiation. The molecular 
events associated with thymic ageing are summarized in figure 26. 
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Figure 26. Model of molecular mechanisms in thymic ageing 
 
It has been demonstrated in the present work that Wnt4 and LAP2α are key regulators in 
physiological and induced ageing. The tightly regulated balance of these two factors determines the 
rate of thymic senescence. Details of the signal transduction of the ageing process raises the 
possibility to find molecular targets for restoration of the physiological T-cell out-put or to find 
therapeutic targets in laminopathies, where lamins including LAP2α − a member of lamin protein 
family – play an important role. 
 55
8. Conclusions  
  
Main conclusions of the thesis 
 
1. In mice, similarly to human thymic tissue, the highly organized structure of the thymic 
epithelium becomes disorganized followed by adipose involution making the mouse thymus a 
suitable model to study the molecular background of thymic senescence. 
 
2. Both physiological and glucocorticoid induced senescence are regulated by decreased Wnt4 and 
increased LAP2α signalling.  
 
3. Up-regulation of Wnt4 can protect against adipoid trans-differentiation and thymic involution. 
 
4. Down-regulation of Wnt4 levels initiate EMT (Fig. 25). 
 
5. Up-regulation of LAP2α initiates adipocyte type trans-differentiation (Fig. 25) in the fibroblast 
like cells results of the EMT process. 
 
6. PKCδ is involved in Wnt4 signalling from both Wnt4 receptors, Fz-4 and Fz-6. Nevertheless, 
PKCδ preferentially associates with Fz-6 that receptor transmits negative, β-catenin inhibitory 
signals that leads to suppression of β-catenin dependent gene transcription.  
 
7. The β-catenin target gene, CTGF, and one of its receptors, Fz-8 are up-regulated during thymic 
senescence. As CTGF-Fz-8 signals are involved in a negative feedback loop inhibiting β-catenin 
dependent signalling, this signalling pathway contributes to down-regulation of TEC identity. 
 
8. Thymic ageing is a continuous, multi-component process that is regulated by complex molecular 
interactions leading to suppression of the canonical Wnt pathway allowing adipocyte-type trans-
differentiation (Fig. 26). 
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